ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Respiratory Syncytial Virus Diagnostic Testing Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-10C13967
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global Respiratory Syncytial Virus Diagnostic Testing Market Research Report 2023
BUY CHAPTERS

Global Respiratory Syncytial Virus Diagnostic Testing Market Research Report 2025

Code: QYRE-Auto-10C13967
Report
May 2025
Pages:74
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
F. Hoffmann-La Roche AG
Abbott
Thermo Fisher Scientific
BD (Becton, Dickinson and Company)
QuidelOrtho Corporation
Hologic Inc
Luminex Corporation
Agilent Technologies Inc
Cepheid(Danaher Corporation)
DiaSorin

Respiratory Syncytial Virus Diagnostic Testing Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Respiratory Syncytial Virus Diagnostic Testing Market

Respiratory Syncytial Virus Diagnostic Testing Market

The global market for Respiratory Syncytial Virus Diagnostic Testing was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Respiratory syncytial virus (RSV) is a highly contagious virus that primarily affects the respiratory tract (lungs and breathing passages). It is a common cause of upper and lower respiratory infections in infants, young children, and elderly people. The infection can lead to severe complications such as pneumonia and bronchiolitis.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Respiratory Syncytial Virus Diagnostic Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Respiratory Syncytial Virus Diagnostic Testing.
The Respiratory Syncytial Virus Diagnostic Testing market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Respiratory Syncytial Virus Diagnostic Testing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Respiratory Syncytial Virus Diagnostic Testing companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Respiratory Syncytial Virus Diagnostic Testing Market Report

Report Metric Details
Report Name Respiratory Syncytial Virus Diagnostic Testing Market
CAGR 5%
Segment by Type
Segment by Application
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company F. Hoffmann-La Roche AG, Abbott, Thermo Fisher Scientific, BD (Becton, Dickinson and Company), QuidelOrtho Corporation, Hologic, Inc., Luminex Corporation, Agilent Technologies, Inc., Cepheid (Danaher Corporation), DiaSorin S.p.A.
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Respiratory Syncytial Virus Diagnostic Testing company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Respiratory Syncytial Virus Diagnostic Testing Market report?

Ans: The main players in the Respiratory Syncytial Virus Diagnostic Testing Market are F. Hoffmann-La Roche AG, Abbott, Thermo Fisher Scientific, BD (Becton, Dickinson and Company), QuidelOrtho Corporation, Hologic, Inc., Luminex Corporation, Agilent Technologies, Inc., Cepheid (Danaher Corporation), DiaSorin S.p.A.

What are the Application segmentation covered in the Respiratory Syncytial Virus Diagnostic Testing Market report?

Ans: The Applications covered in the Respiratory Syncytial Virus Diagnostic Testing Market report are Hospitals, Diagnostic Laboratories, Others

What are the Type segmentation covered in the Respiratory Syncytial Virus Diagnostic Testing Market report?

Ans: The Types covered in the Respiratory Syncytial Virus Diagnostic Testing Market report are Antigen Detection Test, Molecular Diagnostic Test, Direct Fluorescent Antibody Test, Diagnostic Imaging, Others

Recommended Reports

Respiratory Diagnostics

Infectious Disease Tests

Respiratory Therapeutics

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Respiratory Syncytial Virus Diagnostic Testing Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Antigen Detection Test
1.2.3 Molecular Diagnostic Test
1.2.4 Direct Fluorescent Antibody Test
1.2.5 Diagnostic Imaging
1.2.6 Others
1.3 Market by Application
1.3.1 Global Respiratory Syncytial Virus Diagnostic Testing Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospitals
1.3.3 Diagnostic Laboratories
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Respiratory Syncytial Virus Diagnostic Testing Market Perspective (2020-2031)
2.2 Global Respiratory Syncytial Virus Diagnostic Testing Growth Trends by Region
2.2.1 Global Respiratory Syncytial Virus Diagnostic Testing Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Respiratory Syncytial Virus Diagnostic Testing Historic Market Size by Region (2020-2025)
2.2.3 Respiratory Syncytial Virus Diagnostic Testing Forecasted Market Size by Region (2026-2031)
2.3 Respiratory Syncytial Virus Diagnostic Testing Market Dynamics
2.3.1 Respiratory Syncytial Virus Diagnostic Testing Industry Trends
2.3.2 Respiratory Syncytial Virus Diagnostic Testing Market Drivers
2.3.3 Respiratory Syncytial Virus Diagnostic Testing Market Challenges
2.3.4 Respiratory Syncytial Virus Diagnostic Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Respiratory Syncytial Virus Diagnostic Testing Players by Revenue
3.1.1 Global Top Respiratory Syncytial Virus Diagnostic Testing Players by Revenue (2020-2025)
3.1.2 Global Respiratory Syncytial Virus Diagnostic Testing Revenue Market Share by Players (2020-2025)
3.2 Global Respiratory Syncytial Virus Diagnostic Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Respiratory Syncytial Virus Diagnostic Testing Revenue
3.4 Global Respiratory Syncytial Virus Diagnostic Testing Market Concentration Ratio
3.4.1 Global Respiratory Syncytial Virus Diagnostic Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Respiratory Syncytial Virus Diagnostic Testing Revenue in 2024
3.5 Global Key Players of Respiratory Syncytial Virus Diagnostic Testing Head office and Area Served
3.6 Global Key Players of Respiratory Syncytial Virus Diagnostic Testing, Product and Application
3.7 Global Key Players of Respiratory Syncytial Virus Diagnostic Testing, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Respiratory Syncytial Virus Diagnostic Testing Breakdown Data by Type
4.1 Global Respiratory Syncytial Virus Diagnostic Testing Historic Market Size by Type (2020-2025)
4.2 Global Respiratory Syncytial Virus Diagnostic Testing Forecasted Market Size by Type (2026-2031)
5 Respiratory Syncytial Virus Diagnostic Testing Breakdown Data by Application
5.1 Global Respiratory Syncytial Virus Diagnostic Testing Historic Market Size by Application (2020-2025)
5.2 Global Respiratory Syncytial Virus Diagnostic Testing Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Respiratory Syncytial Virus Diagnostic Testing Market Size (2020-2031)
6.2 North America Respiratory Syncytial Virus Diagnostic Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Respiratory Syncytial Virus Diagnostic Testing Market Size by Country (2020-2025)
6.4 North America Respiratory Syncytial Virus Diagnostic Testing Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Respiratory Syncytial Virus Diagnostic Testing Market Size (2020-2031)
7.2 Europe Respiratory Syncytial Virus Diagnostic Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Respiratory Syncytial Virus Diagnostic Testing Market Size by Country (2020-2025)
7.4 Europe Respiratory Syncytial Virus Diagnostic Testing Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Respiratory Syncytial Virus Diagnostic Testing Market Size (2020-2031)
8.2 Asia-Pacific Respiratory Syncytial Virus Diagnostic Testing Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Respiratory Syncytial Virus Diagnostic Testing Market Size by Region (2020-2025)
8.4 Asia-Pacific Respiratory Syncytial Virus Diagnostic Testing Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Respiratory Syncytial Virus Diagnostic Testing Market Size (2020-2031)
9.2 Latin America Respiratory Syncytial Virus Diagnostic Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Respiratory Syncytial Virus Diagnostic Testing Market Size by Country (2020-2025)
9.4 Latin America Respiratory Syncytial Virus Diagnostic Testing Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Respiratory Syncytial Virus Diagnostic Testing Market Size (2020-2031)
10.2 Middle East & Africa Respiratory Syncytial Virus Diagnostic Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Respiratory Syncytial Virus Diagnostic Testing Market Size by Country (2020-2025)
10.4 Middle East & Africa Respiratory Syncytial Virus Diagnostic Testing Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 F. Hoffmann-La Roche AG
11.1.1 F. Hoffmann-La Roche AG Company Details
11.1.2 F. Hoffmann-La Roche AG Business Overview
11.1.3 F. Hoffmann-La Roche AG Respiratory Syncytial Virus Diagnostic Testing Introduction
11.1.4 F. Hoffmann-La Roche AG Revenue in Respiratory Syncytial Virus Diagnostic Testing Business (2020-2025)
11.1.5 F. Hoffmann-La Roche AG Recent Development
11.2 Abbott
11.2.1 Abbott Company Details
11.2.2 Abbott Business Overview
11.2.3 Abbott Respiratory Syncytial Virus Diagnostic Testing Introduction
11.2.4 Abbott Revenue in Respiratory Syncytial Virus Diagnostic Testing Business (2020-2025)
11.2.5 Abbott Recent Development
11.3 Thermo Fisher Scientific
11.3.1 Thermo Fisher Scientific Company Details
11.3.2 Thermo Fisher Scientific Business Overview
11.3.3 Thermo Fisher Scientific Respiratory Syncytial Virus Diagnostic Testing Introduction
11.3.4 Thermo Fisher Scientific Revenue in Respiratory Syncytial Virus Diagnostic Testing Business (2020-2025)
11.3.5 Thermo Fisher Scientific Recent Development
11.4 BD (Becton, Dickinson and Company)
11.4.1 BD (Becton, Dickinson and Company) Company Details
11.4.2 BD (Becton, Dickinson and Company) Business Overview
11.4.3 BD (Becton, Dickinson and Company) Respiratory Syncytial Virus Diagnostic Testing Introduction
11.4.4 BD (Becton, Dickinson and Company) Revenue in Respiratory Syncytial Virus Diagnostic Testing Business (2020-2025)
11.4.5 BD (Becton, Dickinson and Company) Recent Development
11.5 QuidelOrtho Corporation
11.5.1 QuidelOrtho Corporation Company Details
11.5.2 QuidelOrtho Corporation Business Overview
11.5.3 QuidelOrtho Corporation Respiratory Syncytial Virus Diagnostic Testing Introduction
11.5.4 QuidelOrtho Corporation Revenue in Respiratory Syncytial Virus Diagnostic Testing Business (2020-2025)
11.5.5 QuidelOrtho Corporation Recent Development
11.6 Hologic, Inc.
11.6.1 Hologic, Inc. Company Details
11.6.2 Hologic, Inc. Business Overview
11.6.3 Hologic, Inc. Respiratory Syncytial Virus Diagnostic Testing Introduction
11.6.4 Hologic, Inc. Revenue in Respiratory Syncytial Virus Diagnostic Testing Business (2020-2025)
11.6.5 Hologic, Inc. Recent Development
11.7 Luminex Corporation
11.7.1 Luminex Corporation Company Details
11.7.2 Luminex Corporation Business Overview
11.7.3 Luminex Corporation Respiratory Syncytial Virus Diagnostic Testing Introduction
11.7.4 Luminex Corporation Revenue in Respiratory Syncytial Virus Diagnostic Testing Business (2020-2025)
11.7.5 Luminex Corporation Recent Development
11.8 Agilent Technologies, Inc.
11.8.1 Agilent Technologies, Inc. Company Details
11.8.2 Agilent Technologies, Inc. Business Overview
11.8.3 Agilent Technologies, Inc. Respiratory Syncytial Virus Diagnostic Testing Introduction
11.8.4 Agilent Technologies, Inc. Revenue in Respiratory Syncytial Virus Diagnostic Testing Business (2020-2025)
11.8.5 Agilent Technologies, Inc. Recent Development
11.9 Cepheid (Danaher Corporation)
11.9.1 Cepheid (Danaher Corporation) Company Details
11.9.2 Cepheid (Danaher Corporation) Business Overview
11.9.3 Cepheid (Danaher Corporation) Respiratory Syncytial Virus Diagnostic Testing Introduction
11.9.4 Cepheid (Danaher Corporation) Revenue in Respiratory Syncytial Virus Diagnostic Testing Business (2020-2025)
11.9.5 Cepheid (Danaher Corporation) Recent Development
11.10 DiaSorin S.p.A.
11.10.1 DiaSorin S.p.A. Company Details
11.10.2 DiaSorin S.p.A. Business Overview
11.10.3 DiaSorin S.p.A. Respiratory Syncytial Virus Diagnostic Testing Introduction
11.10.4 DiaSorin S.p.A. Revenue in Respiratory Syncytial Virus Diagnostic Testing Business (2020-2025)
11.10.5 DiaSorin S.p.A. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
F. Hoffmann-La Roche AG
Abbott
Thermo Fisher Scientific
BD (Becton, Dickinson and Company)
QuidelOrtho Corporation
Hologic Inc
Luminex Corporation
Agilent Technologies Inc
Cepheid(Danaher Corporation)
DiaSorin
List of Tables
 Table 1. Global Respiratory Syncytial Virus Diagnostic Testing Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Antigen Detection Test
 Table 3. Key Players of Molecular Diagnostic Test
 Table 4. Key Players of Direct Fluorescent Antibody Test
 Table 5. Key Players of Diagnostic Imaging
 Table 6. Key Players of Others
 Table 7. Global Respiratory Syncytial Virus Diagnostic Testing Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 8. Global Respiratory Syncytial Virus Diagnostic Testing Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 9. Global Respiratory Syncytial Virus Diagnostic Testing Market Size by Region (2020-2025) & (US$ Million)
 Table 10. Global Respiratory Syncytial Virus Diagnostic Testing Market Share by Region (2020-2025)
 Table 11. Global Respiratory Syncytial Virus Diagnostic Testing Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 12. Global Respiratory Syncytial Virus Diagnostic Testing Market Share by Region (2026-2031)
 Table 13. Respiratory Syncytial Virus Diagnostic Testing Market Trends
 Table 14. Respiratory Syncytial Virus Diagnostic Testing Market Drivers
 Table 15. Respiratory Syncytial Virus Diagnostic Testing Market Challenges
 Table 16. Respiratory Syncytial Virus Diagnostic Testing Market Restraints
 Table 17. Global Respiratory Syncytial Virus Diagnostic Testing Revenue by Players (2020-2025) & (US$ Million)
 Table 18. Global Respiratory Syncytial Virus Diagnostic Testing Market Share by Players (2020-2025)
 Table 19. Global Top Respiratory Syncytial Virus Diagnostic Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Respiratory Syncytial Virus Diagnostic Testing as of 2024)
 Table 20. Ranking of Global Top Respiratory Syncytial Virus Diagnostic Testing Companies by Revenue (US$ Million) in 2024
 Table 21. Global 5 Largest Players Market Share by Respiratory Syncytial Virus Diagnostic Testing Revenue (CR5 and HHI) & (2020-2025)
 Table 22. Global Key Players of Respiratory Syncytial Virus Diagnostic Testing, Headquarters and Area Served
 Table 23. Global Key Players of Respiratory Syncytial Virus Diagnostic Testing, Product and Application
 Table 24. Global Key Players of Respiratory Syncytial Virus Diagnostic Testing, Date of Enter into This Industry
 Table 25. Mergers & Acquisitions, Expansion Plans
 Table 26. Global Respiratory Syncytial Virus Diagnostic Testing Market Size by Type (2020-2025) & (US$ Million)
 Table 27. Global Respiratory Syncytial Virus Diagnostic Testing Revenue Market Share by Type (2020-2025)
 Table 28. Global Respiratory Syncytial Virus Diagnostic Testing Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 29. Global Respiratory Syncytial Virus Diagnostic Testing Revenue Market Share by Type (2026-2031)
 Table 30. Global Respiratory Syncytial Virus Diagnostic Testing Market Size by Application (2020-2025) & (US$ Million)
 Table 31. Global Respiratory Syncytial Virus Diagnostic Testing Revenue Market Share by Application (2020-2025)
 Table 32. Global Respiratory Syncytial Virus Diagnostic Testing Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 33. Global Respiratory Syncytial Virus Diagnostic Testing Revenue Market Share by Application (2026-2031)
 Table 34. North America Respiratory Syncytial Virus Diagnostic Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 35. North America Respiratory Syncytial Virus Diagnostic Testing Market Size by Country (2020-2025) & (US$ Million)
 Table 36. North America Respiratory Syncytial Virus Diagnostic Testing Market Size by Country (2026-2031) & (US$ Million)
 Table 37. Europe Respiratory Syncytial Virus Diagnostic Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 38. Europe Respiratory Syncytial Virus Diagnostic Testing Market Size by Country (2020-2025) & (US$ Million)
 Table 39. Europe Respiratory Syncytial Virus Diagnostic Testing Market Size by Country (2026-2031) & (US$ Million)
 Table 40. Asia-Pacific Respiratory Syncytial Virus Diagnostic Testing Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 41. Asia-Pacific Respiratory Syncytial Virus Diagnostic Testing Market Size by Region (2020-2025) & (US$ Million)
 Table 42. Asia-Pacific Respiratory Syncytial Virus Diagnostic Testing Market Size by Region (2026-2031) & (US$ Million)
 Table 43. Latin America Respiratory Syncytial Virus Diagnostic Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 44. Latin America Respiratory Syncytial Virus Diagnostic Testing Market Size by Country (2020-2025) & (US$ Million)
 Table 45. Latin America Respiratory Syncytial Virus Diagnostic Testing Market Size by Country (2026-2031) & (US$ Million)
 Table 46. Middle East & Africa Respiratory Syncytial Virus Diagnostic Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 47. Middle East & Africa Respiratory Syncytial Virus Diagnostic Testing Market Size by Country (2020-2025) & (US$ Million)
 Table 48. Middle East & Africa Respiratory Syncytial Virus Diagnostic Testing Market Size by Country (2026-2031) & (US$ Million)
 Table 49. F. Hoffmann-La Roche AG Company Details
 Table 50. F. Hoffmann-La Roche AG Business Overview
 Table 51. F. Hoffmann-La Roche AG Respiratory Syncytial Virus Diagnostic Testing Product
 Table 52. F. Hoffmann-La Roche AG Revenue in Respiratory Syncytial Virus Diagnostic Testing Business (2020-2025) & (US$ Million)
 Table 53. F. Hoffmann-La Roche AG Recent Development
 Table 54. Abbott Company Details
 Table 55. Abbott Business Overview
 Table 56. Abbott Respiratory Syncytial Virus Diagnostic Testing Product
 Table 57. Abbott Revenue in Respiratory Syncytial Virus Diagnostic Testing Business (2020-2025) & (US$ Million)
 Table 58. Abbott Recent Development
 Table 59. Thermo Fisher Scientific Company Details
 Table 60. Thermo Fisher Scientific Business Overview
 Table 61. Thermo Fisher Scientific Respiratory Syncytial Virus Diagnostic Testing Product
 Table 62. Thermo Fisher Scientific Revenue in Respiratory Syncytial Virus Diagnostic Testing Business (2020-2025) & (US$ Million)
 Table 63. Thermo Fisher Scientific Recent Development
 Table 64. BD (Becton, Dickinson and Company) Company Details
 Table 65. BD (Becton, Dickinson and Company) Business Overview
 Table 66. BD (Becton, Dickinson and Company) Respiratory Syncytial Virus Diagnostic Testing Product
 Table 67. BD (Becton, Dickinson and Company) Revenue in Respiratory Syncytial Virus Diagnostic Testing Business (2020-2025) & (US$ Million)
 Table 68. BD (Becton, Dickinson and Company) Recent Development
 Table 69. QuidelOrtho Corporation Company Details
 Table 70. QuidelOrtho Corporation Business Overview
 Table 71. QuidelOrtho Corporation Respiratory Syncytial Virus Diagnostic Testing Product
 Table 72. QuidelOrtho Corporation Revenue in Respiratory Syncytial Virus Diagnostic Testing Business (2020-2025) & (US$ Million)
 Table 73. QuidelOrtho Corporation Recent Development
 Table 74. Hologic, Inc. Company Details
 Table 75. Hologic, Inc. Business Overview
 Table 76. Hologic, Inc. Respiratory Syncytial Virus Diagnostic Testing Product
 Table 77. Hologic, Inc. Revenue in Respiratory Syncytial Virus Diagnostic Testing Business (2020-2025) & (US$ Million)
 Table 78. Hologic, Inc. Recent Development
 Table 79. Luminex Corporation Company Details
 Table 80. Luminex Corporation Business Overview
 Table 81. Luminex Corporation Respiratory Syncytial Virus Diagnostic Testing Product
 Table 82. Luminex Corporation Revenue in Respiratory Syncytial Virus Diagnostic Testing Business (2020-2025) & (US$ Million)
 Table 83. Luminex Corporation Recent Development
 Table 84. Agilent Technologies, Inc. Company Details
 Table 85. Agilent Technologies, Inc. Business Overview
 Table 86. Agilent Technologies, Inc. Respiratory Syncytial Virus Diagnostic Testing Product
 Table 87. Agilent Technologies, Inc. Revenue in Respiratory Syncytial Virus Diagnostic Testing Business (2020-2025) & (US$ Million)
 Table 88. Agilent Technologies, Inc. Recent Development
 Table 89. Cepheid (Danaher Corporation) Company Details
 Table 90. Cepheid (Danaher Corporation) Business Overview
 Table 91. Cepheid (Danaher Corporation) Respiratory Syncytial Virus Diagnostic Testing Product
 Table 92. Cepheid (Danaher Corporation) Revenue in Respiratory Syncytial Virus Diagnostic Testing Business (2020-2025) & (US$ Million)
 Table 93. Cepheid (Danaher Corporation) Recent Development
 Table 94. DiaSorin S.p.A. Company Details
 Table 95. DiaSorin S.p.A. Business Overview
 Table 96. DiaSorin S.p.A. Respiratory Syncytial Virus Diagnostic Testing Product
 Table 97. DiaSorin S.p.A. Revenue in Respiratory Syncytial Virus Diagnostic Testing Business (2020-2025) & (US$ Million)
 Table 98. DiaSorin S.p.A. Recent Development
 Table 99. Research Programs/Design for This Report
 Table 100. Key Data Information from Secondary Sources
 Table 101. Key Data Information from Primary Sources
 Table 102. Authors List of This Report


List of Figures
 Figure 1. Respiratory Syncytial Virus Diagnostic Testing Picture
 Figure 2. Global Respiratory Syncytial Virus Diagnostic Testing Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Respiratory Syncytial Virus Diagnostic Testing Market Share by Type: 2024 VS 2031
 Figure 4. Antigen Detection Test Features
 Figure 5. Molecular Diagnostic Test Features
 Figure 6. Direct Fluorescent Antibody Test Features
 Figure 7. Diagnostic Imaging Features
 Figure 8. Others Features
 Figure 9. Global Respiratory Syncytial Virus Diagnostic Testing Market Size by Application (2020-2031) & (US$ Million)
 Figure 10. Global Respiratory Syncytial Virus Diagnostic Testing Market Share by Application: 2024 VS 2031
 Figure 11. Hospitals Case Studies
 Figure 12. Diagnostic Laboratories Case Studies
 Figure 13. Others Case Studies
 Figure 14. Respiratory Syncytial Virus Diagnostic Testing Report Years Considered
 Figure 15. Global Respiratory Syncytial Virus Diagnostic Testing Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 16. Global Respiratory Syncytial Virus Diagnostic Testing Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 17. Global Respiratory Syncytial Virus Diagnostic Testing Market Share by Region: 2024 VS 2031
 Figure 18. Global Respiratory Syncytial Virus Diagnostic Testing Market Share by Players in 2024
 Figure 19. Global Top Respiratory Syncytial Virus Diagnostic Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Respiratory Syncytial Virus Diagnostic Testing as of 2024)
 Figure 20. The Top 10 and 5 Players Market Share by Respiratory Syncytial Virus Diagnostic Testing Revenue in 2024
 Figure 21. North America Respiratory Syncytial Virus Diagnostic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. North America Respiratory Syncytial Virus Diagnostic Testing Market Share by Country (2020-2031)
 Figure 23. United States Respiratory Syncytial Virus Diagnostic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Canada Respiratory Syncytial Virus Diagnostic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. Europe Respiratory Syncytial Virus Diagnostic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. Europe Respiratory Syncytial Virus Diagnostic Testing Market Share by Country (2020-2031)
 Figure 27. Germany Respiratory Syncytial Virus Diagnostic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. France Respiratory Syncytial Virus Diagnostic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. U.K. Respiratory Syncytial Virus Diagnostic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Italy Respiratory Syncytial Virus Diagnostic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Russia Respiratory Syncytial Virus Diagnostic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Nordic Countries Respiratory Syncytial Virus Diagnostic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Asia-Pacific Respiratory Syncytial Virus Diagnostic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Asia-Pacific Respiratory Syncytial Virus Diagnostic Testing Market Share by Region (2020-2031)
 Figure 35. China Respiratory Syncytial Virus Diagnostic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Japan Respiratory Syncytial Virus Diagnostic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. South Korea Respiratory Syncytial Virus Diagnostic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Southeast Asia Respiratory Syncytial Virus Diagnostic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. India Respiratory Syncytial Virus Diagnostic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Australia Respiratory Syncytial Virus Diagnostic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Latin America Respiratory Syncytial Virus Diagnostic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Latin America Respiratory Syncytial Virus Diagnostic Testing Market Share by Country (2020-2031)
 Figure 43. Mexico Respiratory Syncytial Virus Diagnostic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Brazil Respiratory Syncytial Virus Diagnostic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Middle East & Africa Respiratory Syncytial Virus Diagnostic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Middle East & Africa Respiratory Syncytial Virus Diagnostic Testing Market Share by Country (2020-2031)
 Figure 47. Turkey Respiratory Syncytial Virus Diagnostic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. Saudi Arabia Respiratory Syncytial Virus Diagnostic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 49. UAE Respiratory Syncytial Virus Diagnostic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 50. F. Hoffmann-La Roche AG Revenue Growth Rate in Respiratory Syncytial Virus Diagnostic Testing Business (2020-2025)
 Figure 51. Abbott Revenue Growth Rate in Respiratory Syncytial Virus Diagnostic Testing Business (2020-2025)
 Figure 52. Thermo Fisher Scientific Revenue Growth Rate in Respiratory Syncytial Virus Diagnostic Testing Business (2020-2025)
 Figure 53. BD (Becton, Dickinson and Company) Revenue Growth Rate in Respiratory Syncytial Virus Diagnostic Testing Business (2020-2025)
 Figure 54. QuidelOrtho Corporation Revenue Growth Rate in Respiratory Syncytial Virus Diagnostic Testing Business (2020-2025)
 Figure 55. Hologic, Inc. Revenue Growth Rate in Respiratory Syncytial Virus Diagnostic Testing Business (2020-2025)
 Figure 56. Luminex Corporation Revenue Growth Rate in Respiratory Syncytial Virus Diagnostic Testing Business (2020-2025)
 Figure 57. Agilent Technologies, Inc. Revenue Growth Rate in Respiratory Syncytial Virus Diagnostic Testing Business (2020-2025)
 Figure 58. Cepheid (Danaher Corporation) Revenue Growth Rate in Respiratory Syncytial Virus Diagnostic Testing Business (2020-2025)
 Figure 59. DiaSorin S.p.A. Revenue Growth Rate in Respiratory Syncytial Virus Diagnostic Testing Business (2020-2025)
 Figure 60. Bottom-up and Top-down Approaches for This Report
 Figure 61. Data Triangulation
 Figure 62. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIS Group of Schools

SIMILAR REPORTS

Respiratory Syncytial Virus RSV Testing Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Respiratory Syncytial Virus RSV Diagnostics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
RSV Diagnostics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Pediatric Respiratory Syncytial Virus Infection Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Respiratory Syncytial Virus Treatment Market Research Report 2024
Global Children Respiratory Syncytial Virus RSV Testing Market Research Report 2024
Respiratory Diseases Diagnostic Testing Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Respiratory Syncytial Virus Diagnostic Tests Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Respiratory Syncytial Virus RSV Infections Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Anti Respiratory Syncytial Virus Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Respiratory Viruses Tests Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Respiratory Syncytial Virus RSV Antigen and Antibody Reagent Market Research Report 2024
Global Respiratory Syncytial Virus Vaccine for Children Market Research Report 2024
PCR For Respiratory Infection Diagnostic Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Respiratory Syncytial Virus Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Respiratory Syncytial Virus Therapeutic Drugs Market Research Report 2024
Global Children Respiratory Syncytial Virus Therapeutics Market Research Report 2024
RSV Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Respiratory Syncytial Virus Vaccine for the Elderly Market Research Report 2024
Viral Diagnostic Test Kits Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

RELATED REPORTS

Global Hepatitis B Virus Core Antibody Diagnostic Kits Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-21N6899
Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Global Pediatric Vaccines Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-13M6952
Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Global Poliomyelitis Vaccines Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-29X7355
Tue Sep 09 00:00:00 UTC 2025

Add to Cart

Global Varicella Virus (Chickenpox) Vaccine Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-28B293
Tue Sep 09 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions